Carla Moran Selected Research

Megalencephaly

1/2017	Contrasting Phenotypes in Resistance to Thyroid Hormone Alpha Correlate with Divergent Properties of Thyroid Hormone Receptor α1 Mutant Proteins.
1/2017	Anemia in Patients With Resistance to Thyroid Hormone α: A Role for Thyroid Hormone Receptor α in Human Erythropoiesis.
8/2014	Resistance to thyroid hormone caused by a mutation in thyroid hormone receptor (TR)α1 and TRα2: clinical, biochemical, and genetic analyses of three related patients.
11/2013	An adult female with resistance to thyroid hormone mediated by defective thyroid hormone receptor α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carla Moran Research Topics

Disease

11	Hypothyroidism 11/2022 - 08/2015
6	Constipation 01/2021 - 11/2013
5	Graves Disease (Basedow Disease) 02/2020 - 03/2012
4	Hyperthyroidism 11/2022 - 03/2016
4	Multiple Sclerosis 01/2021 - 01/2018
4	Megalencephaly 01/2017 - 11/2013
3	Adenoma (Adenomas) 01/2022 - 05/2019
3	Thyrotoxicosis 01/2022 - 01/2019
3	Apraxias (Dyspraxia) 01/2017 - 08/2014
2	Primary Hyperparathyroidism 01/2022 - 05/2019
2	Relapsing-Remitting Multiple Sclerosis 01/2021 - 01/2019
2	Neutropenia 01/2021 - 07/2020
2	Familial Dysalbuminemic Hyperthyroxinemia 02/2020 - 07/2014
2	Graves Ophthalmopathy 07/2019 - 01/2019
2	Thyroiditis 07/2019 - 01/2018
2	Anemia 01/2017 - 01/2017
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Exanthema (Rash) 01/2021
1	Hyperthyroxinemia 01/2021
1	Insulin Resistance 01/2021
1	Pigmented Nevus (Melanocytic Nevus) 01/2021
1	COVID-19 07/2020
1	Infections 07/2020
1	Thyroid Diseases (Thyroid Disease) 02/2020
1	Autoimmune Hypothyroidism 02/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Addison Disease (Addison's Disease) 01/2020
1	Carcinoma (Carcinomatosis) 05/2019
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 05/2019
1	Multiple Endocrine Neoplasia Type 1 05/2019
1	Hyperplasia 05/2019
1	Spontaneous Abortion (Miscarriage) 05/2019
1	Psychogenic Polydipsia 01/2019
1	Allan-Herndon-Dudley syndrome 01/2019
1	Nephrogenic Diabetes Insipidus 01/2019
1	Sepsis (Septicemia) 01/2019
1	Ataxia (Dyssynergia) 12/2017
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2017
1	Neoplasms (Cancer) 12/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2017
1	Cardiomyopathies (Cardiomyopathy) 09/2017
1	Heart Failure 09/2017
1	Goiter 09/2017
1	Facies 09/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2017
1	Abdominal Pain (Pain, Abdominal) 03/2016

Drug/Important Bio-Agent (IBA)

15	Thyroid HormonesIBA 01/2022 - 11/2013
5	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2022 - 08/2014
3	Antithyroid Agents (Antithyroid Drugs)IBA 07/2020 - 09/2017
3	thyrotropin-binding inhibitory immunoglobulinIBA 02/2020 - 03/2012
3	Biomarkers (Surrogate Marker)IBA 02/2020 - 08/2015
3	Alemtuzumab (Campath)FDA Link 07/2019 - 01/2018
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022 - 09/2017
2	Parathyroid Hormone (Parathormone)IBA 01/2022 - 05/2019
2	Hormones (Hormone)IBA 01/2022 - 03/2012
2	Iodide Peroxidase (Deiodinase)IBA 01/2021 - 03/2012
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021 - 01/2017
2	AlbuminsIBA 02/2020 - 07/2014
2	3,3',5-triiodothyroacetic acid (Triac)IBA 01/2019 - 09/2017
2	Monoclonal AntibodiesIBA 01/2019 - 12/2017
1	Co-Repressor ProteinsIBA 01/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2021
1	Bexarotene (LGD1069)FDA Link 01/2021
1	Cyclin D1IBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	LipidsIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	Propylthiouracil FDA Link 02/2020
1	GlucocorticoidsIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2020
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 07/2019
1	Pharmaceutical PreparationsIBA 07/2019
1	AutoantibodiesIBA 07/2019
1	CalciumIBA 05/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	LithiumIBA 01/2019
1	SaltsIBA 01/2019
1	Antidiuretic AgentsIBA 01/2019
1	Biotin (Vitamin H)FDA Link 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	pembrolizumabIBA 12/2017
1	Immune Checkpoint InhibitorsIBA 12/2017
1	CarbimazoleIBA 09/2017
1	AcidsIBA 09/2017
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2017
1	Fibrinogen (Factor I)FDA Link 03/2016
1	fibrin fragment D (D-dimer)IBA 03/2016
1	von Willebrand FactorIBA 03/2016
1	Ser Transfer RNAIBA 03/2016

Therapy/Procedure

9	Therapeutics 02/2020 - 11/2013
2	Parathyroidectomy 01/2022 - 05/2019
1	Highly Active Antiretroviral Therapy (HAART) 07/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Thyroidectomy 01/2018
1	Immunotherapy 12/2017